In a new personalised nutrition pact, Italian botanicals firm Indena are to use Onegevity’s capabilities in gut microbiome testing to identify botanical ingredients that best produce person-specific benefits.
The incidence of Milk Thistle material that contains little or no silymarin (the active constituents) is ‘relatively high’ and represents an ‘ongoing problem’, according to a new bulletin from the ABC-AHP-NCNPR Botanical Adulterants Prevention Program...
This week, the ingredient supplier announced that its proprietary blend of β-glucogallin, cocos nucifera, and selenopeptides has been granted a patent in Mexico for the ability to protect dermal papilla cells.
As sales of dietary supplements and natural products remain high – and many companies report record sales – the strain on the supply chain is immense, and for botanicals in particular, and that means a difficult 2021 could be on the horizon.
The high prevalence of dietary supplementation use in the athletic population means there is a risk of inadvertent doping for those users who don’t do their research or get their information from reliable sources.
The latest ruling on health claims from the European Court of Justice is expected to boost the confidence of botanical manufacturers during the ‘on hold’ grey period after a health claim has been submitted to regulators but before approval has been secured.
An Italian team has described a method to produce micronised powders and extracts enriched with polyphenols obtained from agricultural waste, offering environmental as well as metabolic health benefits.
The UK’s Association for the Cannabinoid Industry (ACI) is to conduct a new safety study that coincides with updated advice from the country’s Food Safety Agency that highlights a lack of research in this area.